CRISPR/Cas9-Mediated Insertion of HIV Long Terminal Repeat within BACH2 Promotes Expansion of T Regulatory–like Cells

Author:

Christian Michelle L.1,Dapp Michael J.2ORCID,Scharffenberger Samuel C.1ORCID,Jones Hank1,Song Chaozhong2,Frenkel Lisa M.1345ORCID,Krumm Anthony2,Mullins James I.256,Rawlings David J.137ORCID

Affiliation:

1. *Seattle Children’s Research Institute, Seattle, WA;

2. †Department of Microbiology, University of Washington, School of Medicine, Seattle, WA;

3. ‡Department of Pediatrics, University of Washington, School of Medicine, Seattle, WA;

4. §Department of Laboratory Medicine, University of Washington, School of Medicine, Seattle, WA;

5. ¶Department of Global Health, University of Washington, School of Medicine, Seattle, WA;

6. ‖Department of Medicine, University of Washington, School of Medicine, Seattle, WA; and

7. #Department of Immunology, University of Washington, School of Medicine, Seattle, WA

Abstract

Abstract One key barrier to curative therapies for HIV is the limited understanding of HIV persistence. HIV provirus integration sites (ISs) within BACH2 are common, and almost all sites mapped to date are located upstream of the start codon in the same transcriptional orientation as the gene. These unique features suggest the possibility of insertional mutagenesis at this location. Using CRISPR/Cas9-based homology-directed repair in primary human CD4+ T cells, we directly modeled the effects of HIV integration within BACH2. Integration of the HIV long terminal repeat (LTR) and major splice donor increased BACH2 mRNA and protein levels, altered gene expression, and promoted selective outgrowth of an activated, proliferative, and T regulatory–like cell population. In contrast, introduction of the HIV-LTR alone or an HIV-LTR-major splice donor construct into STAT5B, a second common HIV IS, had no functional impact. Thus, HIV LTR-driven BACH2 expression modulates T cell programming and leads to cellular outgrowth and unique phenotypic changes, findings that support a direct role for IS-dependent HIV-1 persistence.

Funder

Seattle Children's Research Institute

HHS | National Institutes of Health

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3